nach oben

Erschienen in:

01.05.2011 | Review

Current knowledge on PB1-F2 of influenza A viruses

verfasst von: Andi Krumbholz, Anja Philipps, Hartmut Oehring, Katja Schwarzer, Annett Eitner, Peter Wutzler, Roland Zell

Erschienen in: Medical Microbiology and Immunology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Almost 10 years ago, an eleventh protein of influenza A viruses was discovered in a search for CD8+ T-cell epitopes. This protein was named PB1-F2 since it is encoded in the +1 reading frame of the PB1 gene segment. Various studies have shown that PB1-F2 has a pleiotropic effect: (1) The protein can induce apoptosis in a cell type-dependent manner, (2) PB1-F2 is able to promote inflammation, and (3) finally it up-regulates viral polymerase activity by its interaction with the PB1 subunit. These properties could contribute to an enhanced pathogenicity. However, the underlying mechanism is not fully understood yet. New data suggest that some effects of PB1-F2 are strain-specific and host-specific.

Sauerbrei A, Schmidt-Ott R, Hoyer H, Wutzler P (2009) Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 198:93–101PubMedCrossRef

Buda S, Haas W (2009) Epidemiologie und Pathogenese der Influenza. In: Haas W (ed) Influenza. Urban & Fischer, München, pp 23–34CrossRef

Bouvier NM, Palese P (2008) The biology of influenza viruses. Vaccine 26(Suppl 4):D49–D53PubMedCrossRef

Michaelis M, Doerr HW, Cinatl J Jr (2009) Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol 198:175–183PubMedCrossRef

Palese P, Shaw ML (2007) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 1647–1689

Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, Anderson EC, Barclay WS, Digard P (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83:8021–8031PubMedCrossRef

Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312PubMedCrossRef

Krejnusova I, Gocnikova H, Bystricka M, Blaskovicova H, Polakova K, Yewdell J, Bennink J, Russ G (2009) Antibodies to PB1-F2 protein are induced in response to influenza A virus infection. Arch Virol 154:1599–1604PubMedCrossRef

Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6:e1000049PubMedCrossRef

10.

Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, Wutzler P (2007) Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88:536–546PubMedCrossRef

11.

Zell R, Krumbholz A, Wutzler P (2006) Influenza A virus PB1-F2 gene. Emerg Infect Dis 12:1607–1608 (author reply 1608–1609)

12.

Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih SR (2010) Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol 84:10051–10062PubMedCrossRef

13.

Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW (2003) The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77:7214–7224PubMedCrossRef

14.

Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H (2004) Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578:331–336PubMedCrossRef

15.

Henklein P, Bruns K, Nimtz M, Wray V, Tessmer U, Schubert U (2005) Influenza A virus protein PB1-F2: synthesis and characterization of the biologically active full length protein and related peptides. J Pept Sci 11:481–490PubMedCrossRef

16.

Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J (2004) PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 78:6304–6312PubMedCrossRef

17.

Henkel M, Mitzner D, Henklein P, Meyer-Almes FJ, Moroni A, Difrancesco ML, Henkes LM, Kreim M, Kast SM, Schubert U, Thiel G (2010) The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One 5:e11112PubMedCrossRef

18.

Bruns K, Studtrucker N, Sharma A, Fossen T, Mitzner D, Eissmann A, Tessmer U, Roder R, Henklein P, Wray V, Schubert U (2007) Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem 282:353–363PubMedCrossRef

19.

Chevalier C, Al Bazzal A, Vidic J, Fevrier V, Bourdieu C, Bouguyon E, Le Goffic R, Vautherot JF, Bernard J, Moudjou M, Noinville S, Chich JF, Da Costa B, Rezaei H, Delmas B (2010) PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem 285:13233–13243PubMedCrossRef

20.

Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1:e4PubMedCrossRef

21.

Giam M, Huang DC, Bouillet P (2008) BH3-only proteins and their roles in programmed cell death. Oncogene 27(Suppl 1):S128–S136PubMedCrossRef

22.

Doerner A, Pauschinger M, Badorff A, Noutsias M, Giessen S, Schulze K, Bilger J, Rauch U, Schultheiss HP (1997) Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett 414:258–262PubMedCrossRef

23.

McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6:e1001014PubMedCrossRef

24.

Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976–7983PubMedCrossRef

25.

Coleman JR (2007) The PB1-F2 protein of influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9PubMedCrossRef

26.

McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2:240–249PubMedCrossRef

27.

Sethi S (2002) Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 57:56–61PubMed

28.

Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3:1414–1421PubMedCrossRef

29.

Marjuki H, Scholtissek C, Franks J, Negovetich NJ, Aldridge JR, Salomon R, Finkelstein D, Webster RG (2010) Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol 155:925–934PubMedCrossRef

30.

Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10:1140–1152PubMedCrossRef

31.

Mitzner D, Dudek SE, Studtrucker N, Anhlan D, Mazur I, Wissing J, Jansch L, Wixler L, Bruns K, Sharma A, Wray V, Henklein P, Ludwig S, Schubert U (2009) Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 11:1502–1516PubMedCrossRef

32.

McAuley JL, Zhang K, McCullers JA (2010) The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84:558–564PubMedCrossRef

33.

Trifonov V, Rabadan R (2009) The contribution of the PB1-F2 protein to the fitness of influenza A viruses and its recent evolution in the 2009 influenza A (H1N1) pandemic virus. PLoS Curr Influenza:RRN1006

34.

Ramakrishnan MA, Gramer MR, Goyal SM, Sreevatsan S (2009) A serine12stop mutation in PB1-F2 of the 2009 pandemic (H1N1) influenza A: a possible reason for its enhanced transmission and pathogenicity to humans. J Vet Sci 10:349–351PubMedCrossRef

35.

Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, Pearce MB, Garcia-Sastre A, Tumpey TM, Palese P (2010) PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84:4442–4450PubMedCrossRef

36.

Wanitchang A, Kramyu J, Jongkaewwattana A (2010) Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res 147:145–148PubMedCrossRef

37.

Lu G, Rowley T, Garten R, Donis RO (2007) FluGenome: a web tool for genotyping influenza A virus. Nucleic Acids Res 35:W275–W279PubMedCrossRef

38.

Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10:512–526PubMed

39.

Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599PubMedCrossRef

40.

Schmidt HA, Strimmer K, Vingron M, von Haeseler A (2002) TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18:502–504PubMedCrossRef

Titel: Current knowledge on PB1-F2 of influenza A viruses
verfasst von: Andi Krumbholz
Anja Philipps
Hartmut Oehring
Katja Schwarzer
Annett Eitner
Peter Wutzler
Roland Zell
Publikationsdatum: 01.05.2011
Verlag: Springer-Verlag
Erschienen in: Medical Microbiology and Immunology / Ausgabe 2/2011
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-010-0176-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Current knowledge on PB1-F2 of influenza A viruses

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate

Monitoring prevalence of varicella-zoster virus clades in Germany

Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection

The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures

Real-time PCR assay and a synthetic positive control for the rapid and sensitive detection of the emerging resistance gene New Delhi Metallo-β-lactamase-1 (bla NDM-1)

Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin